K2M Group Holdings Inc  

(Public, NASDAQ:KTWO)   Watch this stock  
Find more results for K2M, Inc
17.01
-0.20 (-1.16%)
Real-time:   1:50PM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 16.73 - 17.61
52 week 10.10 - 23.82
Open 17.18
Vol / Avg. 264,172.00/398,863.00
Mkt cap 705.25M
P/E     -
Div/yield     -
EPS -0.86
Shares 41.49M
Beta     -
Inst. own 64%
Aug 3, 2016
Q2 2016 K2M Group Holdings Inc Earnings Call - 5:00PM EDT - Add to calendar
Aug 3, 2016
Q2 2016 K2M Group Holdings Inc Earnings Release - 4:00PM EDT - Add to calendar
Jun 21, 2016
K2M Group Holdings Inc at JMP Securities Life Sciences Conference - Webcast
Jun 15, 2016
K2M Group Holdings Inc at William Blair Growth Stock Conference
Jun 15, 2016
K2M Group Holdings Inc Annual Shareholders Meeting (Estimated)
Jun 14, 2016
K2M Group Holdings Inc Annual Shareholders Meeting
May 23, 2016
K2M Group Holdings Inc at UBS Global Healthcare Conference
May 2, 2016
Q1 2016 K2M Group Holdings Inc Earnings Call
May 2, 2016
Q1 2016 K2M Group Holdings Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin -18.09% -18.15%
Operating margin -17.63% -16.79%
EBITD margin - -5.25%
Return on average assets -11.02% -11.64%
Return on average equity -14.46% -14.39%
Employees 481 -
CDP Score - -

Address

600 Hope Pkwy SE
LEESBURG, VA 20175-4428
United States - Map
+1-703-7773155 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

K2M Group Holdings, Inc. is a medical device company focused on designing, developing and commercializing spine technologies and techniques. The Company's spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor. The Company is engaged in designing, development and commercialization of products for patients suffering from degenerative spinal conditions. Its products consist of implants, disposables and instruments, which are marketed and sold primarily to hospitals for use by spine surgeons. The Company's product portfolio contains over 70 product lines that are used in spine surgeries, minimally invasive spine (MIS) and degenerative surgeries. It markets or sells its products in the United States and over 36 other countries. The Company's technologies include MESA, Rail 4D, Quicket Deformity, CAPRI, SERENGETI, RAVINE, EVEREST, CASCADIA and tifix.

Officers and directors

Daniel A. Pelak Chairman of the Board
Age: 62
Bio & Compensation  - Reuters
Eric D. Major President, Chief Executive Officer, Director
Age: 45
Bio & Compensation  - Reuters
Gregory S. Cole CPA Chief Financial Officer
Age: 44
Bio & Compensation  - Reuters
George Z. Moratis Global Accounting Officer (Principal Accounting Officer)
Age: 47
Bio & Compensation  - Reuters
Kostuik P. John Chief Medical Officer, Director
Age: 77
Bio & Compensation  - Reuters
Brett P. Brodnax Director
Age: 50
Bio & Compensation  - Reuters
Carlos Antonio Ferrer Director
Age: 57
Bio & Compensation  - Reuters
Paul B. Queally Director
Age: 50
Bio & Compensation  - Reuters
Sean M. Traynor Director
Age: 46
Bio & Compensation  - Reuters
Michael A Turpin Director
Age: 53
Bio & Compensation  - Reuters